Search

everythinglearnresearchcommunity

for

Search:↓

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Topical immunomodulators are effective and safe for treating immune-related skin conditions.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Current treatments for alopecia show no significant long-term benefits.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Combining microdermabrasion with steroid injections improves hair regrowth in scalp alopecia areata.

A woman was allergic to quinine in her anti-hair loss lotion.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.